Literature DB >> 26296570

RNA interference of influenza A virus replication by microRNA-adapted lentiviral loop short hairpin RNA.

Fang Xu1, Guanqun Liu1, Qiang Liu1, Yan Zhou1.   

Abstract

Limitations of the current vaccines and antivirals against influenza A virus (IAV) pandemic underscore the urgent need for developing novel anti-influenza strategies. RNA interference (RNAi) induced by small interfering RNA (siRNA) has become a powerful new means to inhibit viral infection in a gene-specific manner. However, the efficacy of the siRNA delivery platform and the relatively high cost of administration have hindered widespread application of siRNA. In this study, we developed a microRNA (miRNA)-30-based lentivirus delivery system by embedding a synthetic short hairpin RNA (shRNA) stem into the context of endogenous precursor of miRNA-30 (shRNAmir) to express a silencer of the influenza gene. We showed that the miRNA-based lentivirus vector was able to express and process a single nucleoprotein (NP)-targeting shRNAmir, which could potently inhibit IAV replication. We further showed that miRNA-based lentivirus vector carrying tandemly linked NP and polymerase PB1 shRNAmirs could express and process double shRNAmirs. Despite the relatively low levels of NP and PB1 miRNAs produced in the stably transduced cells, the combination of two miRNAs exerted a great degree of inhibition on influenza infection. Given the advantage of combinatorial RNAi in preventing emergence of mutant virus, miRNA-based lentiviral vectors are valuable tools for anitiviral activities. To the best of our knowledge, this is the first study demonstrating that a miRNA-based RNAi strategy can be applied for better control of influenza virus infection.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26296570     DOI: 10.1099/jgv.0.000247

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  8 in total

Review 1.  MicroRNA mediated regulation of immunity against gram-negative bacteria.

Authors:  Jonathon Keck; Rishein Gupta; Lane K Christenson; Bernard P Arulanandam
Journal:  Int Rev Immunol       Date:  2017-08-11       Impact factor: 5.311

2.  MiR-1/133 attenuates cardiomyocyte apoptosis and electrical remodeling in mice with viral myocarditis.

Authors:  Wei Li; Mengmeng Liu; Cuifen Zhao; Cai Chen; Qingyu Kong; Zhifeng Cai; Dong Li
Journal:  Cardiol J       Date:  2019-04-17       Impact factor: 2.737

3.  Inhibition of Ongoing Influenza A Virus Replication Reveals Different Mechanisms of RIG-I Activation.

Authors:  GuanQun Liu; Yao Lu; Qiang Liu; Yan Zhou
Journal:  J Virol       Date:  2019-03-05       Impact factor: 5.103

Review 4.  The Influenza Virus Polymerase Complex: An Update on Its Structure, Functions, and Significance for Antiviral Drug Design.

Authors:  Annelies Stevaert; Lieve Naesens
Journal:  Med Res Rev       Date:  2016-08-29       Impact factor: 12.944

Review 5.  Potential Role of MicroRNAs in the Regulation of Antiviral Responses to Influenza Infection.

Authors:  Thi Hiep Nguyen; Xiaoming Liu; Zhen Zhong Su; Alan Chen-Yu Hsu; Paul S Foster; Ming Yang
Journal:  Front Immunol       Date:  2018-07-04       Impact factor: 7.561

6.  Identification of cellular microRNA miR-188-3p with broad-spectrum anti-influenza A virus activity.

Authors:  Huan Cui; Chunmao Zhang; Zongzheng Zhao; Cheng Zhang; Yingying Fu; Jiaming Li; Guanxi Chen; Mengxi Lai; Zhixiang Li; Shishan Dong; Ligong Chen; Zhaoyang Li; Chengyu Wang; Juxiang Liu; Yuwei Gao; Zhendong Guo
Journal:  Virol J       Date:  2020-01-30       Impact factor: 4.099

7.  Exosomes function as nanoparticles to transfer miR-199a-3p to reverse chemoresistance to cisplatin in hepatocellular carcinoma.

Authors:  Kun Zhang; Chu-Xiao Shao; Jin-de Zhu; Xin-Liang Lv; Chao-Yong Tu; Chuan Jiang; Min-Jie Shang
Journal:  Biosci Rep       Date:  2020-07-31       Impact factor: 3.840

8.  In Vivo siRNA Delivery Using JC Virus-like Particles Decreases the Expression of RANKL in Rats.

Authors:  Daniel B Hoffmann; Kai O Böker; Stefan Schneider; Ellen Eckermann-Felkl; Angelina Schuder; Marina Komrakova; Stephan Sehmisch; Jens Gruber
Journal:  Mol Ther Nucleic Acids       Date:  2016-03-22       Impact factor: 10.183

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.